TWD 72.7
(-0.41%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 1.91 Billion TWD | 2.5% |
2022 | 1.86 Billion TWD | -15.16% |
2021 | 2.2 Billion TWD | 2.45% |
2020 | 2.14 Billion TWD | 11.1% |
2019 | 1.93 Billion TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 2.48 Billion TWD | 44.75% |
2024 Q1 | 1.71 Billion TWD | -10.48% |
2023 Q4 | 1.91 Billion TWD | -15.24% |
2023 FY | 1.91 Billion TWD | 2.5% |
2023 Q1 | 1.74 Billion TWD | -6.57% |
2023 Q3 | 2.25 Billion TWD | -7.26% |
2023 Q2 | 2.43 Billion TWD | 39.78% |
2022 Q4 | 1.86 Billion TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Allied Biotech Corporation | 796.6 Million TWD | -140.4% |
GeneFerm Biotechnology Co., Ltd. | 152.07 Million TWD | -1159.243% |
Easywell Biomedicals, Inc. | 386.34 Million TWD | -395.685% |
Synmosa Biopharma Corporation | 2.43 Billion TWD | 21.51% |
Orient EuroPharma Co., Ltd. | 4.84 Billion TWD | 60.453% |
Center Laboratories, Inc. | 5.62 Billion TWD | 65.947% |
Tien Liang BioTech Co., Ltd. | 84.65 Million TWD | -2162.068% |
Orient Pharma Co., Ltd. | 716.92 Million TWD | -167.118% |
InnoPharmax Inc. | 21.49 Million TWD | -8807.596% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 160.83 Million TWD | -1090.718% |
Excelsior Biopharma Inc. | 377.4 Million TWD | -407.424% |
DV Biomed Co., Ltd. | 387.69 Million TWD | -393.955% |
Foresee Pharmaceuticals Co., Ltd. | 228.25 Million TWD | -738.986% |
Handa Pharmaceuticals, Inc. | 13.24 Million TWD | -14364.079% |
UniPharma Co., Ltd. | 277 Thousand TWD | -691251.625% |
Anxo Pharmaceutical Co., Ltd. | 787.84 Million TWD | -143.075% |
Alar Pharmaceuticals Inc. | 1.4 Million TWD | -135815.117% |
Winston Medical Supply Co., Ltd. | 107.32 Million TWD | -1684.275% |
Mercury Biopharmaceutical Corporation | 42.34 Million TWD | -4422.052% |
Bioray Biotech Co., Ltd | 69.79 Million TWD | -2643.931% |
TSH Biopharm Corporation Limited | 7.84 Million TWD | -24317.238% |